Air pollution and poverty: a deadly combination in idiopathic pulmonary fibrosis?

Competing Interests: Conflict of interest: L. Sesé reports personal fees for consultancy and non-financial support for meeting attendance from Roche/Genentech, non-financial support for meeting attendance from Boehringer Ingelheim, personal fees for consultancy from Chiesi, AstraZeneca and Novartis, outside the submitted work. Conflict of interest: I. Annesi-Maesano has nothing to disclose. Conflict of interest: C. Cavalin has nothing to disclose. Conflict of interest: H. Nunes reports grants and personal fees for consultancy from Roche/Genentech and Boehringer Ingelheim, personal fees for advisory board work from Galapagos, other (clinical trial investigator) from Sanofi, Gilead, Novartis and Galecto Biotech AB, during the conduct of the study; personal fees for advisory board work from Actelion Pharmaceuticals, outside the submitted work.